Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results
Zika Vaccine Research: Complex Steps Toward a Critical Need

Overcoming Zika vaccine development challenges

Minimal Residual Disease Detection: Key Considerations for Clinical...

Current MRD detection landscape, key considerations for each approach, and current advancements...

Leveraging RNA Seq for a robust accurate measure

Presentation from The 2017 Immuno-Oncology Summit In Boston, MA

What can LC-MS offer beyond LBA approaches in the field of large molecule?

Liquid Chromatography-Mass Spectrometry offers many advantages in protein bioanalysis

Optimization of High-Resolution MS Parameters for an Automated...

Presented at the 65th ASMS Conference on Mass Spectrometry and Allied Topics

Copy number detection using Viterbi (Covit)

Presentation from Cancer Genomics Consortium, August 2017

Just When You Thought You Knew Bioanalysis - Protein Bioanalysis by LC-MS

The importance of LC-MS in advancing protein bioanalysis

Minimal Residual Disease Finding the Right Test for the New Definition of...

Measurement of Residual Disease for improved oncology trial outcomes

NGS methods capturing splice variants: Picking the right tool to detect...

Presentation from Precision: Lung Cancer Summit, July 2017

Using Gene Signature Methodologies to Strengthen Immuno-Oncology Trials

Genomic technologies that empower and enhance immuno-oncology trials

Fighting Cancer Biomarkers for Immuno-Oncology Clinical Trials

Using anatomic pathology for biomarker development in clinical trials can help predict and assess...

Technical Innovations Advance Gene Expression Profiling

Small-Volume RNA-seq and Improved SMART-Seq® v4 Workflow